scholarly article | Q13442814 |
P50 | author | Ahmet Karadag | Q92056058 |
Yakup Ilker Yayikci | Q92615887 | ||
P2860 | cites work | The MOS 36-ltem Short-Form Health Survey (SF-36) | Q26778425 |
An Inventory for Measuring Depression | Q26778503 | ||
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update | Q26859134 | ||
The hospital anxiety and depression scale | Q27860968 | ||
Health-related quality of life in patients with long-standing rheumatoid arthritis in the era of biologics: data from the German biologics register RABBIT. | Q30957102 | ||
Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states | Q33222832 | ||
Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score | Q33563148 | ||
2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative | Q34130671 | ||
Improved health outcomes with etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis | Q34538213 | ||
Models of adjustment to chronic illness: using the example of rheumatoid arthritis | Q35832165 | ||
What are the consequences of early rheumatoid arthritis for the individual? | Q35978940 | ||
Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs--results of the British Rheumatoid Outcome Study Group randomized controlled clinic | Q36303507 | ||
The consequences of rheumatoid arthritis: quality of life measures in the individual patient. | Q36307614 | ||
Psychological well-being across 1 year with rheumatoid arthritis: coping resources as buffers of perceived stress. | Q36886397 | ||
Measuring disability and quality of life in established rheumatoid arthritis | Q36942633 | ||
Biologics-based therapy for the treatment of rheumatoid arthritis | Q37968143 | ||
Current understanding of rheumatoid arthritis therapy | Q37987351 | ||
Perceptions of patients with rheumatic diseases on the impact on daily life and satisfaction with their medications: RHEU-LIFE, a survey to patients treated with subcutaneous biological products | Q38633145 | ||
Cost-effectiveness of biologic compared with conventional synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a Register study | Q39646869 | ||
Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years | Q40213181 | ||
Issues in cross-cultural validity: example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford Health Assessment Questionnaire | Q40532152 | ||
The impact of passive coping on rheumatoid arthritis pain | Q40748124 | ||
Comparative Study of Infliximab Therapy and Methotrexate Monotherapy to Improve the Clinical Effect in Rheumatoid Arthritis Patients | Q47659209 | ||
Rheumatoid arthritis: sequences. | Q47887234 | ||
Quality of life and unmet needs in patients with inflammatory arthropathies: results from the multicentre, observational RAPSODIA study | Q48063595 | ||
Impact of rheumatoid arthritis in Turkey: a questionnaire study | Q48072511 | ||
Health-related quality of life and utility in patients receiving biological and non-biological treatments in rheumatoid arthritis | Q48707771 | ||
Anxiety and depression in a community-based rheumatoid arthritis population. | Q51079364 | ||
Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial. | Q51764647 | ||
Rheumatoid arthritis | Q74541001 | ||
Depression in rheumatoid arthritis--underscoring the problem | Q80111111 | ||
The relationship between disease activity and depression in patients with Behcet disease and rheumatoid arthritis | Q84355413 | ||
P433 | issue | 1 | |
P921 | main subject | rheumatoid arthritis | Q187255 |
P304 | page(s) | 12-16 | |
P577 | publication date | 2018-11-30 | |
P1433 | published in | The Eurasian journal of medicine | Q26842207 |
P1476 | title | Effects of Conventional and Biological Drugs Used for the Treatment of Rheumatoid Arthritis on the Quality of Life and Depression | |
P478 | volume | 51 |
Q94517898 | Quality of life and influencing factors of patients with rheumatoid arthritis in Northeast China | cites work | P2860 |
Search more.